Condition
Tumor, Breast
Total Trials
5
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
P 1 (1)
P 2 (3)
Trial Status
Recruiting2
Unknown2
Not Yet Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT06251544Phase 1Not Yet Recruiting
TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer
NCT06129747Phase 2Recruiting
Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast
NCT06092892Phase 2Recruiting
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases
NCT05689112Unknown
Microscopy Imaging of Whole-mount Stained Human Tissues
NCT05007444Phase 2Unknown
Safety and Efficacy Evaluation of the P2Et Extract in Patients With Breast Cancer
Showing all 5 trials